
Dermatological experts emphasize that public health messaging regarding melanoma in India requires recalibration because the cancer predominantly presents on the soles of the feet or under nails rather than sun-exposed areas.
Acral lentiginous melanoma accounts for 35% to 60% of cases in dark-skinned individuals and is frequently misdiagnosed as bruises or fungal infections until the disease advances.
Modern oncology offers advanced therapeutic tools, including immune-checkpoint inhibitors, targeted molecular therapies, and personalised mRNA vaccines combined with pembrolizumab.